Kapłon-Cieślicka, Agnieszka

• Vol 27, No 5 (2020) - Editorial
  Myocardial infarction in the shadow of COVID-19
  Details  PDF
• Vol 25, No 4 (2018) - POSITION PAPER
  Use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation — Messages from the 2018 EHRA
  Details  PDF
• Vol 27, No 6 (2020) - Original articles — Clinical cardiology
  Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation
  Abstract  PDF
• Vol 29, No 2 (2022) - Original articles — Clinical cardiology
  Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease
  Abstract  PDF  HTML
• Vol 28, No 2 (2021) - Editorial
  Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome
  Details  PDF
• Vol 28, No 5 (2021) - Review articles — COVID-19
  Pharmacotherapy of atrial fibrillation in COVID-19 patients
  Abstract  PDF
• Vol 30, No 4 (2023) - Review articles — Clinical cardiology
  Is transesophageal echocardiography necessary before electrical cardioversion in patients treated with non-vitamin K antagonist oral anticoagulants? Current evidence and practical approach
  Abstract  PDF  HTML
• Vol 30, No 6 (2023) - Original articles — Clinical cardiology
  Heart rate control and its predictors in patients with heart failure and sinus rhythm. Data from the European Society of Cardiology Long-Term Registry
  Abstract  PDF  HTML